Research
Comparison of Once-Daily Triple Therapy versus Conventional Triple Therapy for Patient Compliance and the Eradication of Helicobacter pylori Infection
Author(s): Naila Mohiuddin*, Sumaiya Al Hajree, Ruqiya Fatima, Mohammed Mustaneer Akmal, Syed Ibrahim Hassan, Asif Rasheed and Aleem Ahmed Khan
Aim: To compare the effectiveness of once-daily triple therapy with conventional triple therapy for the eradication
of H. pylori. Materials and methods: A prospective comparative study in the gastroenterology unit of a tertiary
care hospital was conducted for 6 months. 180 patients with active peptic disease tested positive for rapid urease
test or 13C-UBT and concomitantly positive for anti-H. pylori antibodies IgG and IgM were given either once-daily
(Tinidazole 1000 mg+Azithromycin 500 mg+Rabeprazole 40 mg) or twice-daily (Amoxicillin 500 mg+Clarithromycin
500 mg+Esomeprazole 40 mg) first-line therapy for ten days. Ten weeks after the completion of therapy rapid urease
test and 13C-UBT were repeated. Adherence and adverse events were evaluated using pill count, structured questionnaires,
and exit interviews... Read More»
DOI:
o
Select your language of interest to view the total content in your interested language